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Background 
 
• Stroke is a major cause of death and long term illness 
• 5% of UK population are affected, around 130 
thousand suffer a new or recurrent stroke each year 
• Common risk factors such as age, gender, smoking, 
diabetes .., don’t account for all the stroke cases 
• Emerging evidence shows that respiratory infections 
and incidence of strokes  may be related  
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Previous studies 
  
• Contradictory evidence: Small study size 
• Design Bias: recall, therapeutic 
• Confounding: ‘healthy user effect’, missing 
different treatments and differences in health 
behaviours in vaccinees. 
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Study aim 
 
 
To investigate whether influenza 
vaccination was associated with a 
reduced risk of stroke.  
 
 • Vaccination season from 01 Sept 2001-31 Aug 2009 
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 • Vaccination season from 01 Sept 2001-31 Aug 2009 
     Vaccination periods: 
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Method 
14 days post-vaccination  
15 -28  days post-vaccination  
29 - 59  days post-vaccination  
60 -90  days post-vaccination  
91-120  days post-vaccination  
121-180  days post-vaccination  
14 days pre-vaccination  
 • Exposure-Base line cut points 
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1 Method 
• Case: medical diagnostic Read/OXMIS codes for first 
stroke entered by GP 
• Index date: first date when GP recorded stroke code 
(fatal/non-fatal) in clinical/referral record 
• In the case-series method the Cases act as Controls 
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1 Method 
• Cut-off points for risk periods and seasons were 
calculated for each year. 
•  There were eight pre-defined risk periods including: 
the baseline period for each interval: 1-14 days before 
vaccination and; 1-14 days; 15-28 days; 29-59 days; 60-
90 days; 91-120 days; 121-180 days post vaccination. 
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1 Method 
• 1-14 days pre-vaccination  considered as a separate 
interval: a stroke event occurring during this period is 
likely to affect the subsequent likelihood of receiving an 
influenza vaccination.  
•  Seasonality was included by dividing the risk periods 
into one of four quarterly seasons: Sept. to Nov.; Dec. 
to Feb.; March to May and June to Aug. 
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1 Method 
• The vaccination timings were split into: 
 Early (1 September to 15 November)         and 
 Late (16 November to 30 April) vaccinations. 
 
Analysis 
  
• The incidence rate of stroke in fixed time periods 
after vaccination was compared with the incidence 
rate during a baseline period.  
• Statistical modelling with conditional Poisson 
regression in Stata 12 was employed to compute 
incidence rate ratios (IRR).  
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Descriptive statistics 
• 21,981 first cases of stroke within the observation period 
 
 
• 4,128 cases that either did not receive influenza vaccination 
or had a stroke diagnosis on or before the vaccination date 
were excluded  
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Descriptive statistics 
• 17,853 cases of stroke  considered for the final 
analysis.  
•  52∙8% (9,424) females and 47.2% (8,429) males.  
• The median age at first stroke diagnosis was 75 years 
(interquartile range 68-81 years). 
• 85.7% were aged 65 and over. 
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Main results 
Association between influenza vaccination and stroke 
Risk period Number of cases 
Time at risk 
(person years) 
IRR 
Adjusted 
95% CI 
  N %       
base line period 10001 54.2 53738 1∙00 - 
Pre Vac 1-14 days  334 3.0 2983 0.55 0.49 - 0.61 
Post Vac 1-14 days 462 3.5 3421 0.63 0.57 - 0.69 
15-28 days 552 3.4 3417 0.76 0.70 - 0.84 
29-59 days 1268 7.6 7545 0.83 0.77 - 0.89 
60-90 days 1388 7.6 7506 0.95 0.88 - 1.03 
91-120 days 1363 7.3 7212 0.99 0.92 - 1.06 
121-180 days 2485 13.4 13266 1.02 0.97 - 1.08 
 a Adjusted for seasonality 
b IRR incidence rate ratios. 
c Baseline is between 180 days or 30th of April (whichever came first) after vaccination and 14 days prior to next vaccination 
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Main results 
Seasonally adjusted IRR by gender and timing of vaccination 
 Risk period (days) Gender Vaccination timing 
Female Male 
Early (1 September to 
15 November) 
Late (16 November to 
30 April)   
  
IRR 
Adjusted 
IRR 
Adjusted IRR** 
p<0.01 
Adjusted IRR 
p>0.01 
Adjusted 
  95% CI 95% CI 95% CI 95% CI 
Base line period 1 - 1 - 1 - 1 - 
Pre-vaccination  
1-14 days 0.54 0.46 - 0.64 0.65 0.47 - 0.65 0.55 0.55 - 0.68 0.45 0.17 - 1.21 
Post-vaccination 1-
14 days 0.6 0.52 - 0.69 0.66 0.58 - 0.76 0.62 0.57 - 0.69 0.74 0.38 –1.45 
15-28 days 0.79 0.70 - 0.89 0.74 0.64 - 0.84 0.75 0.69 - 0.83 1.16 0.68 – 2.00 
29-59 days 0.78 0.71 - 0.86 0.88 0.80 - 0.97 0.83 0.77 - 0.88 1.11 0.76 –1.63 
60-90 days 0.95 0.86 - 1.05 0.96 0.86 - 1.07 0.96 0.89 - 1.03 1.08 0.72 –1.61 
91-120 days 0.93 0.84 - 1.03 1.07 0.96 - 1.18 1.00 0.93 - 1.08 0.67 0.38 –1.19 
121-180 days 1.01 0.94 - 1.09 1.04 0.97 - 1.13 1.03 0.97 - 1.08 0.82 0.30 –2.18 
 All IRRs are adjusted for seasonality 
 
Conclusion 
• We used a large, representative and robust 
research database with sufficient power to 
detect effects with precision. 
• Selection bias was minimized by including all 
cases of stroke within the selected time period. 
• Confounders are taken into account naturally 
assuming that they don’t change over the 
observational period. 
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Study strengths and limitations 
Conclusion 
• Since the method assumes that the 
confounders do not change over the 
observational period: it does not account 
for within-person confounding due to 
confounders varying over the 
observational period. 
• We counter this effect by restricting  the 
observational period at first vaccination date. 
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Study strengths and limitations 
Conclusion 
• Influenza vaccination in the preceding 
season is associated with a reduction in 
incidence of stroke. This study supports 
previous studies which have shown a 
beneficial association of influenza 
vaccination in stroke prevention.  
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Thank you 
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